[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100391222":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":28,"locations":38,"responsibleParty":68,"collaborators":10,"id":70,"slug":71,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":72,"sex":77,"minAge":78,"maxAge":10,"enrollmentInfo":79,"targetDuration":10,"studyType":82,"phases":10,"briefSummary":83,"conditions":84,"keywords":86,"overallStatus":41,"whyStopped":10,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Centre Hospitalier Universitaire de Saint Etienne","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Adenocarcinoma group",null,"Patients with Adenocarcinoma will be included. They will have blood sample at the inclusion visit and at 3 months, 6 months, 9 months and 12 months after.",[13],"Biological: Blood sample",{"label":15,"type":10,"description":16,"interventionNames":17},"Control group","Patient with no adenocarcinoma will be included. They will have blood sample at the inclusion visit.",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"BIOLOGICAL","Blood sample","Blood sample will be performed",[9,15],[25],{"name":26,"affiliation":5,"role":27},"Nicolas WILLIET, MD","PRINCIPAL_INVESTIGATOR",[29,34],{"name":26,"role":30,"phone":31,"phoneExt":32,"email":33},"CONTACT","(0)477829029","+33","nicolas.williet@chu-st-etienne.fr",{"name":35,"role":30,"phone":36,"phoneExt":32,"email":37},"Jean-Marc PHELIP, MD-PhD","( 0)477828320","j.marc.phelip@chu-st-etienne.fr",[39,56],{"facility":40,"status":41,"city":42,"state":10,"zip":10,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"CHU Saint-Etienne","RECRUITING","Saint-Etienne","France","FR",{"type":46,"coordinates":47},"Point",[48,49],4.39,45.43389,{"lat":49,"lon":48},[52,53],{"name":26,"role":27,"phone":10,"phoneExt":10,"email":10},{"name":54,"role":55,"phone":10,"phoneExt":10,"email":10},"Jean-Marc PHELIP, MD PhD","SUB_INVESTIGATOR",{"facility":57,"status":41,"city":58,"state":10,"zip":59,"country":43,"countryCode":44,"cosmosGeoPoint":60,"geoPoint":64,"contacts":65},"Institut Cancérologique Lucien Newirth (ICLN)","Saint-Priest-en-Jarez","42270",{"type":46,"coordinates":61},[62,63],4.37678,45.4739,{"lat":63,"lon":62},[66],{"name":67,"role":27,"phone":10,"phoneExt":10,"email":10},"Lea SABAN-ROCHE, MD",{"type":69,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100391222","serum-bank-for-pancreatic-cancer-100391222",false,"NCT04374175","SERum-bank for PANcreatic Cancer","SERPAN","ADENOCARCINOMA GROUP\n\nInclusion Criteria:\n\n* Documented adenocarcinoma (cytology \u002F anatomopathology), all stages, except if the tumor is immediately resectable and does not require preoperative cytological evidence. In this case, the inclusion and the first collection of the sero bank is done preoperatively. The diagnostic confirmation will therefore be made post-operatively at the risk of being excluded in the event of a different diagnosis.\n* At the start of treatment (before surgery \u002F 1st course of chemotherapy)\n* Age ≥ 18 years\n* Patient affiliated or entitled to a social security system\n\nExclusion Criteria:\n\n* Patient refusal\n* Acute renal failure\n* Child-Pugh B or C cirrhosis\n* Patient under guardianship or curators\n* Other synchronous cancer or history of cancer \\\u003C5 years\n* Language barrier\n\nCONTROL GROUP\n\nInclusion Criteria:\n\n* Age ≥ 40 years\n* Patient affiliated or entitled to a social security system\n* Digestive endoscopy for any reason other than cancer or chronic inflammatory bowel disease\n\nExclusion Criteria:\n\n* Patient refusal\n* Acute renal failure\n* Child-Pugh B or C cirrhosis\n* Patient under guardianship or curators\n* Other synchronous cancer or history of cancer \\\u003C5 years","ALL","18 Years",{"count":80,"type":81},400,"ESTIMATED","OBSERVATIONAL","This study is about pancreatic cancer. If the diagnostic cancer is done at an early stage (\\\u003C2cm), the chances of recovery are very good.\n\nBut the main problem is there is not any detections means for this cancer. Sadly, when there is a cancer diagnostic , it's already too late in the majority of cases, because the cancer is in an advanced case.\n\nToday, there is no any effective means of detection... Blood markers can be a simple means of early detection",[85],"Adenocarcinoma",[85,87,88,21],"Pancreatic cancer","Adiponectin","2025-03-17",{"date":91,"type":92},"2025-03-18","ACTUAL",{"date":94,"type":92},"2020-04-01",{"date":96,"type":81},"2026-01-01",{"name":5,"class":6},2]